Boston Scientific to acquire 3D heart mapping firm Rhythmia Medical


Via News Release

“NATICK, Mass., Oct. 8, 2012 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire privately-held Rhythmia Medical, Inc., a developer of next-generation mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter.  Rhythmia Medical is based in Burlington, MA.  The transaction is expected to close by Friday, October 12th.”

Read More…